// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "ZFA MAJOR CT source name MC CV EW INITIATIVE PATO:0000461 instrument NCIT PRIDE:0000590 TMT ... MAGE MIAME BTO PATO organism part README NCIT:C25714 PURPOSE JA THE HUPO DJ FITNESS SP HF MS:1001251 RECOMMEND QY sex cleavage agent details MAY SN USE III FOR DDA EFO INCLUDING age ROW HANCESTRO developmental stage ancestry category II IMPORTANT ID BRENDA ANY PARTICULAR TIP NOTE BUT NCBI YAML STANDARDS MS:1000484 fraction identifier ISA PRIDE:0000659 URL technical replicate exclamation cell type HCD WILL IDF disease stage OF XML HLA HTML CN SRM PEPTIDESEQ individual IMPLIED PRIDE:0000834 FDR VCF MIAPE MONDO WARRANTY LIMITED not data file OPTIONAL SDRF DIA AND proteomics data acquisition method DOID INFRINGE PRIDE:0000831 RIGHTS biological replicate RECOMMENDED CS label PRIDE:0000833 CPTAC PRM spiked compound CF UBERON PP AC PS OR TA URI PMCID EM MHC HEREIN VK IS TO CLO PROTEOMICS PMID SILAC MUST RAW PO characteristics PSI biosample accession number SAMEA file your DISCLAIMS SWATH MT RFC mass EXPRESS AS NCI NT MERCHANTABILITY organism MINOR NOT disease pooled sample SHOULD TAB ENVO LI CELL NCIT:C25683 REQUIRES ALL SAMN PATCH LC MOD CL THAT PRIDE:0000832 WARRANTIES PTM BE SHALL COLUMN PRIDE EBI REQUIRED sample COULD BMC FAIR INFORMATION MS"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "ZFA MAJOR CT MC CV EW INITIATIVE PATO:0000461 instrument NCIT PRIDE:0000590 TMT ... MAGE MIAME BTO PATO organism part README NCIT:C25714 PURPOSE JA THE HUPO DJ FITNESS SP HF MS:1001251 RECOMMEND QY sex cleavage agent details MAY SN USE III FOR DDA EFO INCLUDING age ROW HANCESTRO II BRENDA ANY PARTICULAR BUT NCBI YAML STANDARDS MS:1000484 fraction identifier ISA PRIDE:0000659 URL technical replicate cell type HCD WILL IDF disease stage OF HLA HTML CN SRM PEPTIDESEQ individual IMPLIED PRIDE:0000834 FDR VCF MIAPE MONDO WARRANTY LIMITED data file OPTIONAL SDRF DIA AND proteomics data acquisition method DOID INFRINGE PRIDE:0000831 RIGHTS biological replicate RECOMMENDED CS label PRIDE:0000833 CPTAC PRM spiked compound CF UBERON PP AC PS OR TA URI PMCID EM MHC HEREIN VK IS TO CLO PROTEOMICS PMID SILAC MUST RAW PO PSI biosample accession number SAMEA DISCLAIMS SWATH MT RFC mass EXPRESS AS NCI NT MERCHANTABILITY organism MINOR NOT disease pooled sample SHOULD TAB ENVO LI CELL NCIT:C25683 REQUIRES ALL SAMN PATCH LC MOD CL THAT PRIDE:0000832 WARRANTIES PTM BE SHALL COLUMN PRIDE EBI REQUIRED COULD BMC FAIR INFORMATION MS"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000084 UBERON:0000178 EFO PATO:0000461 SDRF CL:0000235 PDX age MONDO:0100096 developmental stage UBERON:0001969 DOID organism CL:0000815 ID UBERON:0002113 MONDO:0005148 disease NOTE CL:0000236 depletion NCBI UBERON:0000948 CL:0000066 APP UBERON exclamation cell type PATO organism part MONDO:0004989 CL:0000624 UBERON:0000955 CL MONDO:0004975 PATO:0001421 PTM enrichment process synthetic peptide CL:0000057 MUST UBERON:0002107 PO xenograft COVID MAY MONDO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000084 UBERON:0000178 EFO PATO:0000461 SDRF CL:0000235 PDX age MONDO:0100096 developmental stage UBERON:0001969 DOID organism CL:0000815 ID UBERON:0002113 MONDO:0005148 disease CL:0000236 depletion NCBI UBERON:0000948 CL:0000066 APP UBERON cell type PATO organism part MONDO:0004989 CL:0000624 UBERON:0000955 CL MONDO:0004975 PATO:0001421 PTM enrichment process synthetic peptide CL:0000057 MUST UBERON:0002107 PO xenograft COVID MAY MONDO"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27966 TNM staging NCIT:C15632 Dukes stage NCIT:C18206 NCI MONDO:0005044 NCIT SDRF HANCESTRO dose NCIT:C65106 NCIT:C4870 ancestry category PR IMPORTANT GDPR ID body mass index MONDO:0005148 treatment status Ann Arbor stage compound NCIT:C15262 exclamation NCIT:C53554 pre-existing condition organism part TNM disease stage sampling time point NCIT:C28078 HIPAA weight HANCESTRO:0005 AJCC IV NCIT:C28076 menopausal status NCIT:C65108 CHEBI:28748 NCIT:C71732 individual treatment response NCIT:C27971 breast cancer subtype NCIT:C65107 ER tumor grade HANCESTRO:0009 smoking status MONDO treatment CHEBI:27899"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27966 TNM staging NCIT:C15632 Dukes stage NCIT:C18206 NCI MONDO:0005044 NCIT SDRF HANCESTRO dose NCIT:C65106 NCIT:C4870 ancestry category PR GDPR ID body mass index MONDO:0005148 treatment status Ann Arbor stage compound NCIT:C15262 NCIT:C53554 pre-existing condition organism part TNM disease stage sampling time point NCIT:C28078 HIPAA weight HANCESTRO:0005 AJCC IV NCIT:C28076 menopausal status NCIT:C65108 CHEBI:28748 NCIT:C71732 individual treatment response NCIT:C27971 breast cancer subtype NCIT:C65107 ER tumor grade HANCESTRO:0009 smoking status MONDO treatment CHEBI:27899"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "CV collision energy UNIMOD MS:1001917 PRIDE:0000590 TMT MS:1002523 depletion SCX MS1 scan range MS:1000598 CID MS:1002631 README fragment mass tolerance precursor mass tolerance HF MS:1001251 cleavage agent details MS:1001303 MS:1001045 scan window lower limit dissociation method UNIMOD:21 UNIMOD:4 PRIDE:0000565 IAA NOTE TIP SH fraction identifier MS:1000484 TCEP exclamation HCD ETD UNIMOD:1 UNIMOD:35 PAGE PRIDE:0000561 modification parameters MS:1001313 reduction reagent MS:1000084 MS:1000081 SDRF DIA NCE RECOMMENDED PRIDE:0000564 UVPD label MS:1000264 MS:1000133 MS:1003246 CAA PP AC TA SILAC DTT MS:1000443 TOF PSI MS:1001309 MT scan window upper limit MS:1001306 NT SDS OLS PRIDE:0000551 MOD MS2 mass analyzer MS:1000422 alkylation reagent PRIDE REQUIRED fractionation method PRIDE:0000553 PRIDE:0000285 IAM MS"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "CV collision energy UNIMOD MS:1001917 PRIDE:0000590 TMT MS:1002523 depletion SCX MS1 scan range MS:1000598 CID MS:1002631 fragment mass tolerance precursor mass tolerance HF MS:1001251 cleavage agent details MS:1001303 MS:1001045 scan window lower limit dissociation method UNIMOD:21 UNIMOD:4 PRIDE:0000565 IAA SH fraction identifier MS:1000484 TCEP HCD ETD UNIMOD:1 UNIMOD:35 PAGE PRIDE:0000561 modification parameters MS:1001313 reduction reagent MS:1000084 MS:1000081 SDRF DIA NCE RECOMMENDED PRIDE:0000564 UVPD label MS:1000264 MS:1000133 MS:1003246 CAA PP AC TA SILAC DTT MS:1000443 TOF PSI MS:1001309 MT scan window upper limit MS:1001306 NT SDS OLS PRIDE:0000551 MOD MS2 mass analyzer MS:1000422 alkylation reagent PRIDE REQUIRED fractionation method PRIDE:0000553 PRIDE:0000285 IAM MS"
  }
];
